
Robert W. Downs
Examiner (ID: 17152)
| Most Active Art Unit | 2308 |
| Art Unit(s) | 2762, 4762, 2309, 2308, 2165 |
| Total Applications | 581 |
| Issued Applications | 448 |
| Pending Applications | 24 |
| Abandoned Applications | 109 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16604800
[patent_doc_number] => 10905784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
[patent_app_type] => utility
[patent_app_number] => 15/892440
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28885
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15892440
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/892440 | Radiolabeled anti-LAG3 antibodies for immuno-PET imaging | Feb 8, 2018 | Issued |
Array
(
[id] => 16465941
[patent_doc_number] => 20200367478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => METHOD FOR ESTABLISHING ULCERATIVE COLITIS ANIMAL MODEL AND USE OF SAID MODEL
[patent_app_type] => utility
[patent_app_number] => 16/463578
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463578
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463578 | METHOD FOR ESTABLISHING ULCERATIVE COLITIS ANIMAL MODEL AND USE OF SAID MODEL | Feb 7, 2018 | Abandoned |
Array
(
[id] => 12817420
[patent_doc_number] => 20180164312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => 4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/890646
[patent_app_country] => US
[patent_app_date] => 2018-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15890646
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/890646 | 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof | Feb 6, 2018 | Issued |
Array
(
[id] => 15243347
[patent_doc_number] => 10507183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-17
[patent_title] => Cleavable lipids
[patent_app_type] => utility
[patent_app_number] => 15/887693
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25811
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15887693
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/887693 | Cleavable lipids | Feb 1, 2018 | Issued |
Array
(
[id] => 15145203
[patent_doc_number] => 20190351079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => COMPOSITIONS AND METHODS FOR CANCER IMAGING AND RADIOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/479234
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16479234
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/479234 | Compositions and methods for cancer imaging and radiotherapy | Jan 29, 2018 | Issued |
Array
(
[id] => 12766012
[patent_doc_number] => 20180147172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => Compositions for Mitigating Head Trauma
[patent_app_type] => utility
[patent_app_number] => 15/878288
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878288
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/878288 | Compositions for Mitigating Head Trauma | Jan 22, 2018 | Abandoned |
Array
(
[id] => 15206481
[patent_doc_number] => 20190365927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => COMPOSITION FOR PHOTODYNAMIC THERAPY USING GENE EXPRESSING FLUORESCENT PROTEIN AND PHOTOSENSITIZER, AND PHOTODYNAMIC THERAPY METHOD USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/478175
[patent_app_country] => US
[patent_app_date] => 2018-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478175
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/478175 | COMPOSITION FOR PHOTODYNAMIC THERAPY USING GENE EXPRESSING FLUORESCENT PROTEIN AND PHOTOSENSITIZER, AND PHOTODYNAMIC THERAPY METHOD USING SAME | Jan 15, 2018 | Abandoned |
Array
(
[id] => 15083625
[patent_doc_number] => 20190336623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => TREATMENT OF CANCER CELLS OVEREXPRESSING SOMATOSTATIN RECEPTORS USING OCREOTIDE DERIVATIVES CHELATED TO RADIOISOTOPES
[patent_app_type] => utility
[patent_app_number] => 16/477623
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477623
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/477623 | Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes | Jan 11, 2018 | Issued |
Array
(
[id] => 16784967
[patent_doc_number] => 10987366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Methods and compositions for protection of cells and tissues from computed tomography radiation
[patent_app_type] => utility
[patent_app_number] => 15/862171
[patent_app_country] => US
[patent_app_date] => 2018-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10111
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15862171
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/862171 | Methods and compositions for protection of cells and tissues from computed tomography radiation | Jan 3, 2018 | Issued |
Array
(
[id] => 15797343
[patent_doc_number] => 20200121814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => HER3 Peptides for Imaging and Radiotherapy
[patent_app_type] => utility
[patent_app_number] => 16/475020
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16475020
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/475020 | HER3 peptides for imaging and radiotherapy | Dec 28, 2017 | Issued |
Array
(
[id] => 18574313
[patent_doc_number] => 11730819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Peptide derivatives having novel linkage structures
[patent_app_type] => utility
[patent_app_number] => 16/472242
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 21
[patent_no_of_words] => 16747
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472242 | Peptide derivatives having novel linkage structures | Dec 19, 2017 | Issued |
Array
(
[id] => 13297705
[patent_doc_number] => 20180200389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => PHOTOACOUSTIC VOLTAGE-SENSITIVE DYES FOR IN VIVO IMAGING
[patent_app_type] => utility
[patent_app_number] => 15/837891
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837891
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837891 | PHOTOACOUSTIC VOLTAGE-SENSITIVE DYES FOR IN VIVO IMAGING | Dec 10, 2017 | Abandoned |
Array
(
[id] => 12904960
[patent_doc_number] => 20180193495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING
[patent_app_type] => utility
[patent_app_number] => 15/832371
[patent_app_country] => US
[patent_app_date] => 2017-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15832371
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/832371 | POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING | Dec 4, 2017 | Abandoned |
Array
(
[id] => 12808882
[patent_doc_number] => 20180161464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
[patent_app_type] => utility
[patent_app_number] => 15/829311
[patent_app_country] => US
[patent_app_date] => 2017-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15829311
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/829311 | Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging | Nov 30, 2017 | Issued |
Array
(
[id] => 18887696
[patent_doc_number] => 11866457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Clearing agent
[patent_app_type] => utility
[patent_app_number] => 16/463577
[patent_app_country] => US
[patent_app_date] => 2017-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 10152
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463577 | Clearing agent | Nov 23, 2017 | Issued |
Array
(
[id] => 16648826
[patent_doc_number] => 10925980
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Molecular probes and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/821943
[patent_app_country] => US
[patent_app_date] => 2017-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 44
[patent_no_of_words] => 26750
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821943
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821943 | Molecular probes and methods of use | Nov 23, 2017 | Issued |
Array
(
[id] => 12680671
[patent_doc_number] => 20180118723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => FLUORESCENT COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/817561
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15817561
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/817561 | Fluorescent compounds | Nov 19, 2017 | Issued |
Array
(
[id] => 12724546
[patent_doc_number] => 20180133349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => Radiolabeled GRPR-Antagonists For Diagnostic Imaging and Treatment of GRPR-Positive Cancer
[patent_app_type] => utility
[patent_app_number] => 15/817776
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15817776
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/817776 | Radiolabeled GRPR-Antagonists For Diagnostic Imaging and Treatment of GRPR-Positive Cancer | Nov 19, 2017 | Abandoned |
Array
(
[id] => 15880511
[patent_doc_number] => 10646580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Oligosaccharide conjugates for targeting bacteria and uses related thereto
[patent_app_type] => utility
[patent_app_number] => 15/801892
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 14033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15801892
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/801892 | Oligosaccharide conjugates for targeting bacteria and uses related thereto | Nov 1, 2017 | Issued |
Array
(
[id] => 12580950
[patent_doc_number] => 20180085479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => CATHEPSIN-BINDING COMPOUNDS BOUND TO A CARRIER AND THEIR DIAGNOSTIC USE
[patent_app_type] => utility
[patent_app_number] => 15/791999
[patent_app_country] => US
[patent_app_date] => 2017-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15791999
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/791999 | Cathepsin-binding compounds bound to a carrier and their diagnostic use | Oct 23, 2017 | Issued |